Arkolith/Insider Trading/IRWD/Form 4

MCCOURT Thomas A

Chief Executive Officer, DirectorIRONWOOD PHARMACEUTICALS INC (IRWD) · full profile →Form 4 · filed May 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8K
Net Open-Market Flow
-$8K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2025Grant(A)540K—$01.7M
May 16, 2025Sell(S)13K$0.58$8K1.1M

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-075191) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML